Aldo Maggioni to Italy
This is a "connection" page, showing publications Aldo Maggioni has written about Italy.
Connection Strength
0.227
-
[COVID-19 trials: surfing between expectations and illusions, looking forward to evidence]. G Ital Cardiol (Rome). 2020 Jul; 21(7):479-482.
Score: 0.037
-
COVID-19 trials in Italy: A call for simplicity, top standards and global pooling. Int J Cardiol. 2020 11 01; 318:160-164.
Score: 0.037
-
The use of antiplatelet agents after an acute coronary syndrome in a large community Italian setting of more than 12 million subjects. Eur Heart J Acute Cardiovasc Care. 2019 Sep; 8(6):527-535.
Score: 0.033
-
Use of lipid lowering drugs in patients at very high risk of cardiovascular events: An analysis on nearly 3,000,000 Italian subjects of the ARNO Observatory. Int J Cardiol. 2017 Nov 01; 246:62-67.
Score: 0.029
-
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients. J Cardiovasc Comput Tomogr. 2021 Sep-Oct; 15(5):421-430.
Score: 0.010
-
Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy. Drugs Aging. 2020 12; 37(12):925-933.
Score: 0.010
-
The battle against COVID-19: mortality in Italy. Eur Heart J. 2020 Jun 07; 41(22):2050-2052.
Score: 0.009
-
Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study. Europace. 2019 Feb 01; 21(2):230-238.
Score: 0.008
-
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation. Eur J Prev Cardiol. 2019 04; 26(6):660-663.
Score: 0.008
-
Target Population of Non-deferrable Surgery and Uncontrolled Severe Bleeding Related to Dabigatran. Cardiovasc Drugs Ther. 2018 06; 32(3):281-286.
Score: 0.008
-
Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial. Metabolism. 2018 06; 83:205-215.
Score: 0.008
-
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes. Eur J Heart Fail. 2018 05; 20(5):888-895.
Score: 0.008
-
Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice. Atherosclerosis. 2018 04; 271:120-127.
Score: 0.008
-
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial. J Am Heart Assoc. 2017 Jul 05; 6(7).
Score: 0.008
-
Regular wine consumption in chronic heart failure: impact on outcomes, quality of life, and circulating biomarkers. Circ Heart Fail. 2015 May; 8(3):428-37.
Score: 0.006